ITOS

Iteos Therapeutics Inc (ITOS)

US
$ 9.270.98%

Price Chart

Key Statistics

Market Cap
$ 445.69M
P/E Ratio
0.00
Revenue (TTM)
$ 35M
Volume
372.78K
52W High
$ 18.13
52W Low
$ 4.80
Dividend Yield
0.00%
Beta
1.49

Technicals

50-Day MA
9.9848
200-Day MA
8.1843
52 Week High
18.13
52 Week Low
4.8

About ITOS

iTeos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients with cancer.

Employees
173
Headquarters
Watertown, MA
CEO
Dr. Michel Detheux Ph.D.

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg